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Introduction
Hematopoiesis is the lifelong process by which all the cells of 
the blood system are produced in a hierarchical manner from a 
small population of hematopoietic stem cells (HSCs), which re-
side in the bone marrow (BM) cavity in adult mammals (Orkin 
and Zon 2008). HSCs give rise to progenitor cells that become 
increasingly lineage restricted and ultimately differentiate into 
all lineages of mature blood cells. As HSCs continually replen-
ish cells that are lost or turned over, they must self-renew to 
maintain themselves over the lifetime of the organism. HSC 
self-renewal is experimentally defined as the capacity for long-
term reconstitution of all blood lineages upon transplantation 
into a recipient (Ema et al., 2006). However, the capacity to 
self-renew is by itself insufficient for lifelong maintenance of a 
functional HSC compartment, as the accumulation of damage 
in  such  long-lived  cells  can  result  in  dysfunctional  hemato-
poiesis including BM failure or leukemic transformation (Lane 
and Gilliland 2010). Adult HSCs reside in specialized micro-
environments, known collectively as the BM niche (Schofield 
1978; Wilson and Trumpp 2006), where they are maintained 
in a quiescent, or dormant, state. It is believed that quiescence 
contributes to HSC longevity and function, perhaps in part by 
minimizing stresses due to cellular respiration and genome 
replication (Eliasson and Jönsson 2010).
In this review, we will focus on mouse hematopoiesis 
and explore the balance between HSC quiescence and prolif-
eration, and how these two processes are regulated by intrin-
sic and extrinsic factors. We will also address the effects of 
aging on the mechanisms of HSC proliferation and quies-
cence, and the consequences of aging on HSC function and 
leukemic transformation.
Developmental origin of HSCs
Although HSCs reside in the BM in adults, this is merely the 
endpoint of an otherwise nomadic journey during embryogene-
sis. Moreover, the quiescent state of HSCs in the adult BM is 
reached only after a period of active cell cycling and prolifera-
tion to generate the blood system during fetal life (Bowie et al., 
2006). Hematopoiesis in the embryo is considered to occur in 
successive waves, with the initial “primitive” wave geared to-
ward the rapid production of red blood cells for oxygen trans-
port but with little HSC activity; the second, or “definitive” 
wave, is characterized by the generation of all lineages of blood 
cells and the production of the first engrafting HSCs. Primitive 
hematopoiesis occurs as early as day E7.5 in the yolk sac blood 
islands (Palis et al., 1999; Medvinsky et al., 2011). The defini-
tive wave of hematopoiesis, on the other hand, occurs in parallel 
in several tissues over a more protracted period of time. Defini-
tive HSCs are found in the aorta-gonad-mesonephros (AGM) 
region and the placenta by E8.5 and E10, respectively, as well 
as in the yolk sac (Medvinsky and Dzierzak 1996; Gekas et al., 
2005; Samokhvalov et al., 2007). Subsequently, HSCs from one 
or more of these sites expand in the fetal liver during the re-
mainder of embryonic life, while their production by the AGM 
and placenta become extinguished (Medvinsky et al., 2011).
By E17.5 and through the first two weeks of postnatal life, 
HSCs leave the liver to colonize the bones via an active recruit-
ment  mechanism  involving  the  CXCL12/SDF-1  chemokine   
receptor CXCR4 (Ma et al., 1998), which regulates HSC hom-
ing and engraftment in the nascent BM environment by activat-
ing the guanine nucleotide exchange factor Vav1, which in turn 
regulates the GTPases Rac and Cdc42 (Cancelas et al., 2005; 
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reflect feedback mechanisms informing HSCs that blood cell 
formation has reached homeostatic levels, or that the develop-
ment of the BM niche has been completed. Transition from   
active cell cycling in fetal HSCs to quiescence in adult HSCs is 
also associated with changes in gene expression programs, in-
cluding a marked reduction in expression of Sox17, a transcrip-
tion factor required for the maintenance of fetal but not adult 
hematopoiesis (Kim et al., 2007).
Interestingly, adult HSCs are not uniformly dormant. In vivo 
experiments assessing cell cycle activity (by measuring re-
tention of BrdU or histone 2B (H2B)-GFP expression pulses) 
in mature HSCs suggest a notable heterogeneity in the degree to 
which HSCs are quiescent (Wilson et al., 2008; Foudi et al., 
2009). These studies propose the subfractionation of the HSC 
compartment into “dormant” and “activated” phenotypes with dis-
tinct rates of cell cycle entry, comprising 5–10% and 90–95% 
of the HSC pool, respectively (Fig. 1). Dormant HSCs are com-
puted to divide only once every 145 d or more, and appear to be 
enriched for long-term reconstitution potential. This small popu-
lation of cells may represent a reservoir of HSC activity kept 
aside in the adult BM to be called upon only by severe hemato-
poietic injury, thus ensuring the maintenance of blood homeo-
stasis. However, recent work in human blood cells indicates that 
human HSCs enter the cell cycle on average once every 40 wk 
(Catlin et al., 2011). Although this finding underscores the con-
siderable physiological difference between humans and rodents 
that must be kept in mind when interpreting studies performed in 
the mouse, it also appears to support the hypothesis that limiting 
cell cycle activity is critical to lifelong HSC maintenance.
Despite the great difference in the frequency by which 
fetal and adult HSCs divide, once in the cell cycle, they transit 
through it at the same slow rates compared with their more dif-
ferentiated progenitor cells due to an extended passage through 
the G1 phase of the cell cycle (Nygren et al., 2006). Thus, the 
decision regarding whether HSCs enter the cell cycle, as op-
posed to how they progress through it, appears to be one of the 
essential  differences  between  fetal  and  adult  hematopoiesis. 
Moreover, disruption of HSC quiescence leads to defects in 
HSC self-renewal and often results in HSC exhaustion (Orford 
and Scadden 2008), hence underscoring the critical importance 
Sanchez-Aguilera et al., 2011). Other factors also contribute to 
HSC localization to the BM either in conjunction with CXCR4, 
such as prostaglandin E2 (PGE2) and the neuronal guidance 
protein Robo4 (Hoggatt et al., 2009; Smith-Berdan et al., 2011), 
or independently from CXCR4 like c-Kit, the calcium-sensing 
receptor (CaR), and the transcription factor Egr1 (Christensen 
et al., 2004; Adams et al., 2006; Min et al., 2008). Thereafter, 
HSCs remain anchored in the BM niche by complex integrin-
dependent mechanisms (Scott et al., 2003; Forsberg and Smith-
Berdan 2009), though small numbers of HSCs will periodically 
migrate from the BM into the circulation and back for short 
periods of time under homeostatic conditions, perhaps as a form 
of immunosurveillance (Massberg et al., 2007; Bhattacharya 
et al., 2009). Taken together, these data underscore the dynamic 
nature of hematopoietic development from embryogenesis 
through adulthood.
Distinct cell cycle activities in fetal and 
adult HSCs
The cell cycle activity of HSCs over the lifetime of an organism 
is equally dynamic, and reflects the needs of the organism at 
different developmental stages. During fetal life, the central 
function of HSCs is to rapidly generate homeostatic levels of 
blood cells for oxygen transport and immune system develop-
ment in the growing organism. In line with this role, between 95 
and 100% of HSCs are actively cycling in the mouse fetal liver 
with a cell cycle transit time between 10–14 h (Fig. 1; Bowie 
et al., 2006; Nygren et al., 2006).
Although HSC residence in the BM during adulthood is 
often associated with quiescence, HSCs do not appear to be-
come quiescent immediately upon seeding the BM, as all HSC 
activity remains confined to the fraction of actively cycling 
lineage-negative (Lin
) BM cells in 3-wk-old weanling mice 
(Bowie et al., 2006). Remarkably, the BM HSC population rap-
idly switches to a quiescent state by 4 wk of age, with only 
5% of total HSCs actively in the cell cycle (defined as S, G2, 
or M phases) thereafter through adult life (Cheshier et al., 1999; 
Bowie et al., 2006; Kiel et al., 2007) (Fig. 1). This abrupt change 
in HSC proliferation activity suggests that HSC quiescence is 
not solely linked to their localization in the BM cavity, but may 
Figure 1.  Distinct cell cycle activity in fetal, 
adult, and old HSCs. HSC cell cycle activity 
and cellular output is highly dynamic through-
out the lifetime of an organism. During fetal life 
(left column), HSCs display a high level of cell 
cycle activity, as their primary role at this stage 
is the genesis of the nascent blood system. Dur-
ing adult life (center column), HSCs reside in 
the BM and enter a predominantly quiescent 
(G0)  state,  generating  a  balanced  myeloid, 
erythroid,  and  lymphoid  output  to  maintain 
blood homeostasis. As individuals age (right 
column),  HSCs  appear  to  remain  predomi-
nantly quiescent, but their function begins to 
degrade (dotted outlines), resulting in the loss 
of erythroid and lymphoid output and bias to-
ward the myeloid lineage. AGM: aorta-gonad-
mesonephros; ND: not determined. See text for 
detailed discussion and references.711 HSC cell cycle regulation • Pietras et al.
Rb Family. The retinoblastoma (Rb) family of transcrip-
tional repressors, including the pRb, p107, and p130 proteins, 
restricts cell cycle entry by repressing E2F gene transcription   
of positive cell cycle regulators, which include E-type cyclins. 
In their hypophosphorylated state, Rb family members restrict 
entry through G1 phase. However, upon phosphorylation by the 
cyclin D–Cdk4/6 complex, Rb family members are partially in-
activated and permit cell cycle progression through G1. Subse-
quent  phosphorylation  by  cyclin  E–Cdk2  further  inactivates 
Rb-mediated inhibition of E2F, resulting in G1 exit and entry 
into S phase. A firm role for Rb family members in the control 
of HSC quiescence was not established until recently, as consid-
erable functional redundancy exists within this family and as 
all members are expressed, albeit at different levels, in HSCs 
(Passegué et al., 2005). For instance, no hematopoietic pheno-
type was observed in p130-deficient mice (Cobrinik et al., 1996), 
and p107 deletion resulted in only a mild myeloid hyperplasia 
(LeCouter et al., 1998). Removal of pRb had also no effect on 
HSC self-renewal as assessed by serial transplantation (Walkley 
and Orkin 2006), and although pRb-deficient mice exhibited 
myeloid expansion, this was shown to be a non-cell autonomous 
effect (Walkley and Orkin 2006; Walkley et al., 2007). Strikingly, 
however, conditional deletion of all three Rb family members in 
of a constitutively low level of cell cycle activity for proper 
function of the blood system during adult life.
Together, these findings underscore the requirement for 
a  complex  network  of  regulatory  mechanisms  in  enforcing   
the balance between HSC quiescence and proliferation, and 
the proper maintenance of blood homeostasis in the adult   
organism. In the following sections, we will discuss the cur-
rent understanding of such intrinsic and extrinsic regulatory 
mechanisms in adult HSCs and highlight the relevant ge-
netic  mouse  models  that  have  contributed  to  this  under-
standing (Table I).
Cell-intrinsic mechanisms regulating  
HSC quiescence
Numerous factors regulate the cell cycle status within a cell; 
however, they can largely be reduced to the competing actions 
of Cdks, which drive cell cycle progression, and Cdk inhibitors 
(CKIs), which blunt progression through the cell cycle (Morgan 
1997). A large body of studies has begun to unravel the mo-
lecular wiring within adult HSCs that mediate their continued 
maintenance in a quiescent, or G0, state, while allowing for their 
rapid  entry  into  the  cell  cycle  to  respond  to  hematopoietic   
demand (Fig. 2).
Table I.  Relevant genetic mouse models that have contributed to the understanding of HSC cell cycle regulation
Category Gene(s) Genetic model HSC cell cycle  
activity
Developmental stage References
Cell-intrinsic mechanisms
Cell cycle regulators pRb/p107/
p130
Mx1-Cre conditional deletion Increased Adult Viatour et al., 2008
CyclinD1/D2/
D3
Triple knockout Decreased Fetal Kozar et al., 2004
Cdk4/6 Double knockout Decreased Fetal Malumbres et al., 2004
p21
Cip1 Knockout Decreased or  
unchanged
Adult Cheng et al., 2000a;  
van Os et al., 2007; 
Foudi et al., 2009
p57
Kip2 Mx1-Cre conditional deletion Increased Adult Matsumoto et al., 2011
p27
Kip1/p57
Kip2 Double knockout;  
fetal liver HSC transplant
Increased Fetal, Adult Zou et al., 2011
p18
ink4c Knockout Increased Adult Yuan et al 2004
Transcription factors p53 Knockout Increased Adult Liu et al., 2009
p53 Hypermorphic allele Decreased Old Dumble et al., 2007
junB More-Cre conditional deletion Increased Adult Santaguida et al., 2009
PI3K pathway Pten Mx1-Cre conditional deletion Increased Adult Yilmaz et al., 2006; 
Zhang et al., 2006
Tsc1 Knockout Increased Adult C. Chen et al., 2008
Akt1/2 Double knockout Decreased Adult Juntilla et al., 2010
myr-Akt Retroviral expression Increased Adult Kharas and Gritsman 
2010
Foxo1/3/4 Triple knockout Increased Adult Tothova et al., 2007
Foxo3 Knockout Increased Adult Miyamoto et al., 2007
Cell-extrinsic mechanisms
Environmental factors Tpo Knockout Increased Fetal, Adult Qian et al., 2007
Ang-1 Retroviral expression Decreased Adult Arai et al., 2004
Kit Hypomorphic allele Increased Fetal, Adult Thorén et al., 2008
Cxcr4 Rosa
Cre-Ert2 conditional deletion Increased Adult Nie et al., 2008
Developmental  
pathways
Dkk Col12.3-driven transgene Increased Adult Fleming et al., 2008
Gli1 Knockout Decreased Adult Merchant et al., 2010JCB • VOLUME 195 • NUMBER 5 • 2011   712
three  D-cyclins  die  during  late  embryogenesis  due  to  heart   
defects and hematopoietic failure with significant reduction in 
peripheral red blood cell numbers (Kozar et al., 2004). Further-
more, D1/2/3-cyclins
/ mice have lower numbers of HSCs and 
progenitor populations in the fetal liver, with decreased fre-
quency of HSCs in S and G2-M stages of the cell cycle. Fetal 
liver cells derived from D1/2/3-cyclins
/ mice are also unable 
to provide short-term reconstitution of irradiated recipient mice 
(Kozar et al., 2004). Cdk4/6
/ mice also display late embry-
onic lethality accompanied by a defect in fetal hematopoiesis 
very similar to the phenotypes observed in D1/2/3-cyclins
/ 
mice,  including  severely  decreased  numbers  of  proliferating 
erythroid progenitors in the fetal liver and of red blood cells cir-
culating in the peripheral blood (Malumbres et al., 2004). These 
findings further underscore the essential requirement for active 
HSC proliferation during fetal blood development and stress 
the importance of the cyclin D–Cdk4/6 complex in fetal HSC 
cell  cycle  progression.  However,  it  is  yet  to  be  established 
whether there is a different requirement for the cyclin D–Cdk4/6 
complex in maintaining the proliferation and functionality of 
adult HSCs.
Ink4 family. The Ink4 family includes the CKIs p15
Ink4b, 
p16
Ink4a, p18
Ink4c, and p19
Ink4d, and a functionally distinct protein, 
p19
ARF that is encoded by an alternate reading frame within the 
Ink4a locus, which also encodes p16
Ink4a (Sherr 2001). The Ink4 
adult mice resulted in a robust cell-intrinsic myeloproliferation 
phenotype leading to the death of the animals by 1–3 mo after 
gene inactivation (Viatour et al., 2008). This was accompanied 
by an increase in both HSC proliferation and absolute cell num-
bers, and by severe defects in HSC self-renewal as BM from 
mice deficient in all three Rb family genes had grossly impaired 
reconstitution after transplantation (Viatour et al., 2008). Taken 
together, these findings indicate that Rb family members play 
critical, albeit overlapping roles in the regulation of HSC quies-
cence and continued self-renewal activity.
D-cyclins  and  Cdk4/6.  Cyclins  and  Cdks  act  up-
stream of the Rb family members to mediate cell cycle entry 
and progression. As the regulation of HSC quiescence funda-
mentally  involves  controlling  whether  HSCs  enter  the  G1 
phase of the cell cycle or remain in G0, the activity of the cyclin   
D–Cdk4/6 complex, which controls progression through G1 in 
response to mitogenic signals, is likely a central determinant of 
HSC cell cycle activity. The D-cyclin family includes cyclin D1 
(Ccnd1), cyclin D2 (Ccnd2), and cyclin D3 (Ccnd3), which are 
all expressed, albeit at different levels, in HSCs (Passegué et al., 
2005). Similar to the Rb gene family, mice deficient for a single 
D-cyclin, or for only one of the two associated Cdks, have mini-
mal hematopoietic defects, hence illustrating the considerable 
functional  redundancy  protecting  this  complex  (Fantl  et  al., 
1995; Malumbres et al., 2004). However, mice deficient in all 
Figure 2.  HSC cell cycle entry is regulated by 
a  complex  network  of  cell-intrinsic  and  cell-
extrinsic factors. The entry of quiescent HSCs 
from G0 into the G1 phase of the cell cycle is 
governed  primarily  via  competing  activating 
and  inhibitory  mechanisms  that  regulate  the 
activity of cyclin–Cdk complexes. The PI3K/
Akt/mTOR pathway, which is activated in re-
sponse to numerous extrinsic signals, is con-
sidered a central activator of HSC cell cycle 
activity, primarily via activation of the cyclin 
D–Cdk4/6 complex. This pathway is heavily 
regulated,  primarily  by  PTEN  and  TSC1/2. 
Moreover, the Ink4 CKI family inhibits cyclin 
D–Cdk4/6 activity, and CIP/KIP family CKIs 
are also capable of inhibiting Cdk4 activity. 
Progression from the G1 to the S phase of the 
cell cycle is regulated by Cyclin E–Cdk2. This 
complex  is  regulated  via  the  CIP/KIP  family 
of Cdk inhibitors, as well as by the Rb fam-
ily. Expression of CIP/KIP family members is 
in turn regulated by transcription factors such 
as Hes1, JunB, and FoxO3a, which are ac-
tivated by extrinsic growth-repressive signals. 
Furthermore, HSC cell cycle activity is subject 
to regulation via p53, either in response to cel-
lular damage or p19
ARF activity. Solid arrows 
indicate  direct  activation/inhibition  events, 
dashed arrows indicate transcriptional regula-
tion events. Functionally related groups of cell 
cycle activators are shaded in green; function-
ally related groups of cell cycle inhibitors are 
shaded in red.713 HSC cell cycle regulation • Pietras et al.
hematopoietic-specific deletion of p57
Kip2 in adult mice suggests 
that p57
Kip2 is in fact critical for maintaining HSC quiescence 
(Matsumoto et al., 2011). In addition, the defective quiescence 
phenotype of p57
Kip2-deficient HSCs is exacerbated by concomi-
tant deletion of either p21
Cip or p27
Kip1, and p27
Kip1 overexpres-
sion is able to compensate for the loss of p57
Kip2 (Matsumoto 
et al., 2011; Zou et al., 2011). Taken together, these studies 
reveal p57
Kip2 as a critical regulator of HSC quiescence in adult 
mice, and suggest some degree of functional redundancies among 
the CIP/KIP family of CKIs. Interestingly, growth-repressive 
signals  such  as TGF-  directly  target  the  p21
Cip  and  p57
Kip2 
genes, suggesting a role for the BM niche in regulating expres-
sion of these CKIs in HSCs (Scandura et al., 2004). Interest-
ingly, p53, a master transcriptional regulator that induces the 
transcription of p21
CIP in addition to a plethora of other genes 
upon cellular insult, also regulates HSC quiescence (Asai et al., 
2011). p53
/ HSCs have increased BrdU incorporation and de-
creased frequency of G0 cells (Liu et al., 2009). Although p53 
deletion increases the numbers of phenotypic HSCs, transplanta-
tion experiments demonstrate that p53
/ HSCs actually have 
decreased functionality, suggesting that p53 positively regulates 
self-renewal, perhaps by restraining HSC activity (TeKippe 
et al., 2003; J. Chen et al., 2008). However, this appears to be in-
dependent of p21
Cip, and may instead be due to the transcription 
of other p53 targets that negatively regulate HSC proliferation, 
particularly Necdin and Gfi-1 (Liu et al., 2009).
PI3K signaling pathway. The phosphatidylinositol-3 
kinase (PI3K) signaling pathway integrates numerous upstream 
signals from activated cytokine receptors and other mitogenic 
stimuli to drive cell proliferation, growth, and survival. Down-
stream targets of the PI3K pathway include the threonine/serine 
kinase Akt, which can both lead to the activation of mammalian 
target of rapamycin (mTOR) and the suppression of the forkhead 
box O (FoxO) family of transcription factors. This pathway is re-
strained through the action of the tumor suppressor phosphatase 
and tensin homologue (PTEN). Specifically, PI3K signaling may 
accelerate cell proliferation by stabilizing D-type cyclins and 
inhibiting  FoxO-dependent  transcription  of  p21
Cip  and  p27
Kip1 
(Massagué  2004).  Attenuation  of  signaling  through  the  PI3K 
pathway is essential to preserve HSC quiescence and long-term 
self-renewal (Warr et al., 2011). Conditional deletion of Pten in 
the hematopoietic system results in an aggressive and deadly 
early-onset myeloproliferative neoplasm (MPN), which is ac-
companied by a threefold increase in the frequency of cycling 
HSCs (Yilmaz et al., 2006; Zhang et al., 2006). Pten
/ HSCs 
also show defective self-renewal activity as they are unable to 
provide long-term engraftment in transplanted mice, which re-
sults in the depletion of the HSC pool in Pten-deficient mice 
(Yilmaz et al., 2006; Zhang et al., 2006). Increased HSC cycling 
and defective self-renewal activity are also observed in a myris-
toylated Akt retroviral transplantation model, which has consti-
tutive Akt activity (Kharas and Gritsman 2010), and in mice 
lacking the tumor suppressor Tsc1, which has unchecked mTOR 
activity (C. Chen et al., 2008). Furthermore, rapamycin, a pharma-
cological inhibitor of mTOR, is able to reverse many of the 
phenotypes associated with Pten deficiency, including the in-
creased proliferation of HSCs (Yilmaz et al., 2006). These results 
proteins all function as antagonists of the cyclin D–Cdk4/6 com-
plex, thereby blocking phosphorylation of Rb family members 
and subsequent entry into S phase. p19
ARF, on the other hand, is 
not a CKI and instead positively regulates p53 (see CIP/KIP 
family section; Sherr 2001). Deletion of both p16
Ink4a and p19
ARF 
through the disruption of the entire Ink4a locus has minimal con-
sequences for HSC activity, consistent with the reported low or 
absent expression of these factors in HSCs (Passegué et al., 
2005). Their limited expression is likely the result of transcrip-
tional repression by Bmi1, a polycomb group family member 
and  chromatin  remodeler  that  is  expressed  preferentially  in 
HSCs  and  actively  represses  the  Ink4a  locus  (Lessard  and 
Sauvageau 2003; Park et al., 2003). Bmi1 deficiency is lethal in 
adult mice due to hematopoietic failure caused by a progressive 
depletion of HSCs (Lessard and Sauvageau 2003; Park et al., 
2003). This result implies that the resulting increase in p16
Ink4a 
and p19
ARF expression caused by Bmi1 removal may completely 
inhibit the infrequent cell cycle entry of adult HSCs, which is 
essential for HSC self-renewal and maintenance of blood homeo-
stasis. The fact that combined deletion of p16
Ink4a and p19
ARF 
rescues the majority of the hematopoietic phenotypes in Bmi1-
deficient mice supports this notion and indicates a critical role 
for Bmi1 in restraining p16
Ink4a and p19
ARF expression in adult 
HSCs (Oguro et al., 2006). In contrast, deletion of p18
Ink4c di-
rectly results in increased numbers of actively cycling HSCs 
without impairment of HSC self-renewal activity, as p18
Ink4c-
deficient cells confer enhanced reconstitution to lethally irradiated 
recipients (Yuan et al., 2004). Notably, p18
Ink4c expression is 
highest in quiescent HSCs, and is significantly decreased in 
actively cycling fetal HSCs relative to adult HSCs, consistent 
with its role as a brake for HSC proliferation (Passegué et al., 
2005; Bowie et al., 2007). This result may also provide some 
molecular basis for the difference in cell cycle activity between 
fetal and adult HSCs. Collectively, these data indicate that sev-
eral of the Ink4 family members are differentially regulated in 
adult HSCs to maintain the proper balance between quies-
cence and proliferation, with p18
Ink4c directly acting to restrict 
cell cycle entry, and Bmi1 preventing expression of p16
Ink4a 
and p19
ARF.
CIP/KIP family. The CIP/KIP family includes the CKIs 
p21
Cip, p27
Kip1, and p57
Kip2, which also restrain entry into S phase 
by inhibiting the activity of the cyclin E–Cdk2 complex. p21
Cip 
is expressed at somewhat greater levels in adult HSCs relative to 
their differentiated progeny or to fetal HSCs (Passegué et al., 
2005; Bowie et al., 2007). Although a role for p21
Cip in regulat-
ing HSC quiescence had initially been suggested (Cheng et al., 
2000a), more recent reports using different mouse backgrounds 
and/or methodologies suggest that the function of p21
Cip in regu-
lating HSC cell cycle activity may be restricted to periods of 
stress  rather  than  during  homeostasis  (Cheng  et  al.,  2000a;   
van Os et al., 2007; Foudi et al., 2009). Aside from p21
Cip, analysis 
of p27
Kip1-deficient mice suggests that p27
Kip1 deficiency alone 
has a limited impact on HSC function and instead appears to   
affect the cell cycle activity of more committed progenitor popula-
tions (Cheng et al., 2000b). Interestingly, although earlier studies 
detected no overt hematopoietic defects in p57
Kip2-deficient mice 
(Yan et al., 1997; Zhang et al., 1997), more recent work using   JCB • VOLUME 195 • NUMBER 5 • 2011   714
activity in specific hematological contexts that have not yet been 
well studied, such as stress or disease (Zhao et al., 2007, 2009).
A wide range of environmental factors, including cyto-
kines, growth factors, and other mediators produced by circulat-
ing immune cells and cells comprising the BM niche, also modulate 
HSC quiescence. In contrast to the previously discussed devel-
opmental pathways, these environmental factors, which include 
the chemokine CXCL12/SDF-1, stem cell factor (SCF), angio-
poietin-1 (Ang-1), and thrombopoietin (TPO), are dispensable 
for fetal hematopoiesis, but are essential to regulate HSC quies-
cence in adult organisms (Wilson et al., 2009). Mice deficient in 
Cxcr4 (SDF-1 receptor), Tpo, Tie-2 (Ang-1 receptor), or carry-
ing a hypomorphic allele of Kit (SCF receptor), all exhibit nor-
mal fetal hematopoiesis followed by increased cell cycle activity 
and progressive loss of the HSC compartment during adult life 
(Nagasawa et al., 1996; Puri and Bernstein 2003; Arai et al., 
2004; Qian et al., 2007; Nie et al., 2008; Thorén et al., 2008). 
Collectively, these results highlight the importance of cell-
extrinsic mechanisms in regulating HSC function, and further 
underscore the importance of quiescence for the maintenance of 
the HSC compartment during adulthood.
A body of evidence suggests that the regulation of lipid raft 
clustering on the surface of HSCs may be a critical determinant of 
HSC quiescence by dictating the level of Akt activation induced 
by cytokine receptors. Quiescent HSCs show minimal amounts 
of lipid raft clustering, while actively proliferating hematopoietic 
progenitor cells have high levels of clustering and Akt pathway 
activation (Yamazaki et al., 2006, 2007). In addition, SCF or 
TPO stimulation of HSCs in in vitro culture conditions lead to 
lipid raft clustering, rapid Akt phosphorylation, and exclusion of 
FoxO3a from the nucleus, resulting in decreased expression of 
p21
Cip and p57
Kip2 and reentry of HSCs into the cell cycle (Yamazaki 
et al., 2006, 2007). Interestingly, TGF- signaling suppresses lipid 
raft clustering in HSCs, hence limiting the activation of Akt in-
duced by SCF or TPO stimulation to a level that likely promotes 
HSC survival but not proliferation (Yamazaki et al., 2009). TGF- 
also directly induces expression of p57
Kip2, and prevents seques-
tration of cyclin D1 (Yamazaki et al., 2009; Scandura et al., 2004). 
Taken together, these results explain a mechanism by which 
TGF- may enforce HSC quiescence, although the relationship 
between TGF- and HSC quiescence has not been directly 
addressed in vivo due to the confounding effect of an auto-
immune condition present in mice lacking TGF- signaling com-
ponents (Larsson et al., 2003). These data may also help explain 
why SCF and TPO are associated with HSC quiescence and not 
proliferation in vivo, as factors such as TGF- that are present in 
the BM niche may prevent activation of Akt by these cytokines. 
Furthermore, TGF- also collaborates with Notch ligands to in-
duce expression of p21
Cip via a mechanism involving the tran-
scription factors junB and Hes1 (Yu et al., 2006; Santaguida 
et al., 2009). Mice deficient in the transcription factor Smad4, 
which interacts with TGF-R–activated Smad2/3, express lower 
levels of Notch1 but the effect of Smad4 deficiency on HSC cell 
cycle activity has not yet been directly studied (Karlsson et al., 
2007). These findings suggest that TGF- and Notch may function 
in an interdependent manner to regulate HSC cell cycle activity. 
In addition, the induction of p21
Cip and p57
Kip2 expression is also 
suggest that PTEN normally restrains HSC entry into the cell 
cycle entry, at least in part, through inhibition of downstream 
mTOR signaling. However, as discussed previously, constitutive 
levels of Akt also repress the activity of FoxO family members. 
Interestingly, FoxO3
/ and FoxO1/3/4
/ mice display increased 
HSC cell cycle activity accompanied by increased levels of reac-
tive oxygen species (ROS), which can be reversed after the   
administration of the ROS scavenger N-acetylcysteine (NAC; 
Miyamoto et al., 2007; Tothova et al., 2007). In contrast, loss of 
PI3K signaling caused by deletion of Akt1/2 results in an in-
creased proportion of HSCs in G0/G1 phase and decreased HSC 
proliferation, which can be rescued in vitro by pharmacologically 
increasing cellular ROS levels (Juntilla et al., 2010). Although 
cellular oxygen levels and HSC proliferation are thought to be di-
rectly associated (Ito et al., 2006; Eliasson and Jönsson 2010; 
Takubo et al., 2010), a direct demonstration of the function of 
ROS in controlling HSC cell cycle in vivo remains to be pro-
vided. Collectively, these studies suggest that HSC quiescence is 
preserved at least in part by limiting activation of the PI3K signal-
ing pathway, which may maintain high levels of FoxO-dependent 
expression of CKIs and minimize ROS production, thereby block-
ing HSC cell cycle progression.
Cell-extrinsic mechanisms regulating  
HSC quiescence
Although quiescence is essential for the self-renewal of adult 
HSCs, they must nonetheless retain the capacity to proliferate 
rapidly, albeit transiently, in response to extrinsic cues that sig-
nal injury or infection. Evidence that cell-extrinsic signals regu-
late the cell-intrinsic mechanisms governing HSC quiescence can 
be inferred from the observation that HSCs enter the cell cycle 
upon pharmacological mobilization in vivo or culture ex vivo 
(Passegué et al., 2005), and from experimental evidence indicat-
ing that osteoblasts and other cellular components of the BM 
niche influence HSC cell cycle status (Wilson et al., 2007).
Part of this mechanism proceeds via a series of conserved 
developmental pathways, including TGF-, Wnts, Notch ligands, 
and the Hedgehog (Hh) pathway, which are all essential for em-
bryonic development and fetal hematopoiesis. Deletion of TGF-
1 or Indian hedgehog (Ihh) lead to defects in fetal erythropoiesis 
resulting in embryonic lethality (Dickson et al., 1995; Cridland 
et al., 2009), whereas Wnt3a-deficient mice show depressed 
numbers of HSCs in the fetal liver (Luis et al., 2009). However, 
conclusive in vivo evidence for their role in adult HSC cell cycle 
regulation has been difficult to generate, as Mx-Cre–driven con-
ditional deletion of Notch, Wnt, and Hh signaling components in 
adult mice do not reveal clear hematopoietic defects or altera-
tions in HSC cell cycle activity (Koch et al., 2008; Maillard et al., 
2008; Gao et al., 2009). This suggests that they are either not ab-
solutely critical in the context of adult hematopoiesis, or that sig-
nificant functional redundancy exists between these and other 
niche signals. Additional work will be required to disentangle the 
complex direct and indirect effects of these developmental path-
ways on adult HSCs in vivo, as well as the relevant receptor–
ligand interactions on both HSCs and/or BM niche cells that 
mediate them. Furthermore, it should be emphasized that these 
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mice (Rossi et al., 2005). However, whether this is a result of   
a true change in self-renewal versus a clonal change in the 
composition  of  the  HSC  compartment  is  currently  debated 
(Cho et al., 2008; Waterstrat and Van Zant 2009; Beerman   
et al., 2010a).
During aging, the additive effects of repeated cellular and 
genomic insults can become apparent, potentially damaging the 
integrity of the HSC pool (Blanpain et al., 2011). Indeed, mice 
deficient for key DNA repair pathway components exhibit 
diminished HSC self-renewal with age and early functional ex-
haustion (Nijnik et al., 2007; Rossi et al., 2007). In fact, long-
lived quiescent HSCs may be particularly susceptible to the 
accumulation of DNA damage over time, as their cell cycle sta-
tus forces them to repair DNA damage using the error-prone 
and mutagenic nonhomologous end joining (NHEJ) mechanism 
(Mohrin et al., 2010). Moreover, HSCs from aged mice exhibit 
increased  phosphorylated  -H2AX  staining,  which  indicates 
increased occurrence of DNA double-strand breaks, and sug-
gests that aging may contribute to the loss of HSC function in 
part due to genomic instability (Rossi et al., 2007). In addition 
to DNA damage, the short-circuiting or overload of epigenetic 
control  mechanisms  regulating  HSC  self-renewal  may  also 
contribute to the pathogenesis of hematological malignancies, 
particularly in the myeloid lineage, later in life (Rossi et al., 
2008). Indeed, deletion of Ten-Eleven-Translocation-2 (Tet2), 
a factor thought to regulate gene silencing via methylation and 
which is commonly mutated in individuals with MPNs, leads to 
aberrant activation of myeloid differentiation gene programs in 
HSCs and subsequent MPN emergence in mice (Ko et al., 2011, 
Li  et  al.,  2011,  Moran-Crusio  et  al.,  2011,  Quivoron  et  al., 
2011). Thus, the appropriate control of HSC cell cycle activity 
may therefore become particularly important in an aging organ-
ism as a means of preventing the outgrowth of damaged clones via 
induction of cell cycle arrest or cellular senescence.
Studies of aged mice show an overall decrease in HSC cell 
cycle activity, with old HSCs undergoing fewer cell divisions 
than young HSCs as assessed by BrdU and N-hydroxysuccinimi-
dyl biotin (NHS-biotin) incorporation (Janzen et al., 2006; Nygren 
and Bryder 2008). These results suggest that Cdks and other acti-
vators of the cell cycle may undergo functional decline or that the 
activity of certain cell cycle checkpoint mechanisms such as CKIs 
may increase with age, hence delaying HSC entry into the cell 
cycle. This latest hypothesis is supported by the observations of 
increased p16
INK4a levels in old HSCs and of better engraftment 
capacity and increased cell cycle activity in old p16
INK4a/ HSCs 
compared with old wild-type HSCs (Janzen et al., 2006). As in-
creased expression of p16
Ink4a is associated with aging in numer-
ous tissues, and its expression correlates with cellular senescence 
(Sharpless and DePinho 2007), it is appealing to suggest that 
p16
Ink4a expression in aged HSCs may result in the cellular senes-
cence of at least a subpopulation of old HSCs. However, another 
group demonstrates no correlation between p16
Ink4a expression 
levels and HSC aging (Attema et al., 2009). Such discrepancies 
may in part be due to heterogeneity among cohorts of aged 
mice, or the sensitivity of different methods used to detect 
p16
Ink4a  expression.  Interestingly,  Bondar  and  Medzhitov 
(2010) elegantly demonstrated that cell competition exists in 
regulated by a number of other BM niche-associated factors, in-
cluding TPO, Wnt, and SDF-1 (Qian et al., 2007; Fleming et al., 
2008; Nie et al., 2008). Collectively, these data indicate that multi-
ple signaling mechanisms activated by developmental pathways 
and environmental factors may converge upon the regulation of 
CKI expression, which in turn might contribute to the prolonged 
passage of HSCs through the G1 phase of the cell cycle.
Regulation of cyclin expression forms another conver-
gence point by which extrinsic signals regulate the internal ma-
chinery governing quiescence in adult HSCs. Mice deficient in 
Cxcr4 have increased levels of cyclin D1, which suggests that 
the CXCR4–SDF-1 pathway impacts on the activity of the 
cyclin D–Cdk4/6 complex and G1 phase progression in HSCs 
(Nie et al., 2008). Notably, TGF- and Notch ligands up-regulate 
CXCR4, and this may account for some of their quiescence-
enforcing activity (Franitza et al., 2002). On the other hand, ac-
tivation of the Wnt and Hh pathways is associated with increased 
expression of cyclin D1 in HSCs, although Wnt signaling is 
typically associated with maintenance of HSC quiescence and 
self-renewal  activity  (Fleming  et  al.,  2008;  Merchant  et  al., 
2010). It may be that signaling through these pathways helps 
to maintain basal expression of cyclin D1 in quiescent HSCs 
(Passegué et al., 2005). Such careful balancing of pro- and anti-
proliferative factors in the BM niche could account for their 
role in enforcing a homeostatic level of HSC quiescence, while 
leaving HSCs sufficiently primed for proliferation in response 
to hematopoietic demand. Recent work suggests that interfer-
ons, a family of inflammatory cytokines, rapidly induce HSC 
cell cycle entry, and this may occur at least in part via activation 
of the Akt pathway (Essers et al., 2009; Baldridge et al., 2010). 
These results confirm that the quiescent state of HSCs is indeed 
quickly reversible, which is likely to be critical for effective 
control of stress conditions such as infection or blood loss.
Taken together, these studies demonstrate that quiescence 
is a dynamic condition that is orchestrated by a careful balance 
between collaborating and opposing extrinsic signals acting on 
various components of the intrinsic cell cycle machinery, which 
directly  control  HSC  proliferation  and  self-renewal  activity 
(Fig. 2). Further studies of the mechanisms by which these ex-
trinsic factors regulate the proliferation of fetal vs. adult HSCs 
will be invaluable in understanding the regulation of the cell 
cycle machinery in HSCs and other stem cells as organisms 
reach maturity. A careful analysis of how these extrinsic factors 
may contribute to the heterogeneity observed in the cycling 
activity of HSC subpopulations should also prove highly informa-
tive (Challen et al., 2010).
Aging and the control of HSC cell  
cycle activity
The hematopoietic system declines with age, resulting in a di-
minished production of adaptive immune cells, termed immuno-
senescence, and an increased incidence of anemia and myeloid 
malignancies (Fig. 1; Beerman et al., 2010b). Although aged 
mice have increased numbers of phenotypic HSCs, the func-
tional capacity of these cells is actually compromised, as evi-
denced by the decrease in long-term multilineage reconstitution 
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system, in which HSCs may have acquired damage, must deal 
with the conflicting requirements of suppressing the outgrowth 
of damaged and/or transformed clones, while at the same time 
producing enough blood cells to maintain homeostasis. The bio-
logical response to this problem appears to err on the side of 
caution, as evidenced by the decreased self-renewal potential 
and reduced cell cycle entry observed in the expanded pool of 
old HSCs. Although it would be tempting to explain these re-
sponses as a p53- and/or p16
Ink4a -driven program of cellular 
senescence that could underlie some of the hematological insuf-
ficiencies observed in the elderly, experimental evidence is still 
needed to confirm this hypothesis. The high incidence of hema-
tological malignancy observed with age suggests that the abil-
ity to arrest damaged HSCs is likely not without fundamental 
limitations, hence supporting the notion that expansion of func-
tionally  deficient  HSC  clones  harboring  defective  cell  cycle 
checkpoints contributes to the aging of the blood system (Kastan 
and Bartek 2004; Bondar and Medzhitov 2010).
Considerable work still remains to be done to fully under-
stand how components of the regulatory networks that control 
cell cycle activity in young adult HSCs may become altered with 
age. For instance, is there a global change in the expression lev-
els of master cell cycle regulators in old HSCs? Although micro-
array analyses have been performed, they do not uncover any 
particular changes in cell cycle machinery or upstream regula-
tory genes in old HSCs, though alterations in the expression of 
genes involved in myeloid and lymphoid differentiation and 
epigenetic regulation are observed (Rossi et al., 2005; Chambers   
et al., 2007). These results suggest that the activity, rather than 
the expression level, of cell cycle regulators is altered in old HSCs, 
which is consistent with the work showing increased mTOR ac-
tivity in old HSCs (Chen et al., 2009). Furthermore, as the acti-
vation level of the cell cycle machinery is in part regulated by 
cell-extrinsic signals, it will be critical to understand the extent 
to which the extracellular environment where HSCs reside, both 
in the niche and systemically, is altered with age and contributes   
to the functional decline of the hematopoietic system.
Taken together, these findings underscore the challenges 
inherent in understanding the cell cycle regulation of a system as 
complex and dynamic as the aging hematopoietic system, as ag-
ing itself appears to alter the cellular context in which these regu-
latory mechanisms operate. It can be speculated that the functional 
decline of the blood system could be in part due to a clonal ex-
pansion of damaged HSC populations that outcompete HSCs 
with intact cell cycle checkpoints. Thus, experimental approaches 
that uncover the extent to which distinct subpopulations of HSCs 
and their output change over time will likely be crucial to our un-
derstanding of how the phenotypic features of aged hematopoie-
sis arise. Understanding how aging affects HSC biology will also 
provide critical insight into the pathogenesis of hematological 
malignancies that result from such an outgrowth of damaged 
HSCs. In turn, the development of targeted therapies that modu-
late the activity of cell cycle checkpoints in HSCs may prove ef-
ficacious in eliminating damaged HSC clones or in reducing their 
output. Such therapies may reestablish favorable conditions for 
the activation of undamaged HSCs and a restoration of effective 
hematopoiesis in aged individuals or patients with hematological 
the HSC compartment and is dependent on the relative levels of 
p53 expression, and a balance between proliferation and senes-
cence responses. This work shows that cells with lower levels of 
p53 outcompete cells with higher p53 levels for BM engraftment, 
resulting in growth arrest and the induction of a senescence- 
related gene expression program in the outcompeted cells, which 
includes p16
Ink4a expression. Furthermore, HSCs from old p53
+/m 
mice, which carry a hypermorphic allele of p53, exhibit decreased 
proliferation and self-renewal capacity relative to old p53
+/+ con-
trols, whereas old p53
+/ HSCs, which have only one functional 
p53 allele, exhibit increased function compared with controls 
(Dumble et al., 2007). Notably, such differences are not observed 
in HSCs from young mice, regardless of p53 status. Collectively, 
these data suggest that p53-dependent checkpoint mechanisms, 
perhaps including but not limited to induction of p16
Ink4a, may in 
part underlie the functional decline and decreased cell cycle ac-
tivity of aged HSCs. This might be due to a combination of cellu-
lar senescence in some HSCs amid an expansion of other 
functionally compromised HSC clones in which cell cycle check-
points have been compromised. Such a model may help explain 
the apparent lack of senescent HSCs observed in the expanded, 
but functionally impaired, HSC compartment of old mice, while 
at the same time accounting for the improved function of the 
HSC pool in aged p16
INK4a/ mice, where otherwise competi-
tively disadvantaged HSC populations may still contribute to 
blood production.
As described previously, mouse models that lead to un-
checked levels of mTOR activity result in a deregulated HSC 
compartment  and  stem  cell  exhaustion  (Yilmaz  et  al.,  2006; 
Zhang et al., 2006; C. Chen et al., 2008). Recent work also indi-
cates  that  mTOR  activity  is  increased  in  aged  HSCs  (Chen   
et al., 2009). Interestingly, pretreatment of aged mice with rapa-
mycin, which inhibits mTOR activity, rescues many of the func-
tional defects observed in old HSCs, including their decreased 
cell  cycle  activity  and  diminished  engraftment  (Chen  et  al., 
2009). At the moment it is quite challenging to integrate this ob-
servation with the aforementioned increase in p16
Ink4a expres-
sion exhibited by the old HSCs because increased mTOR 
activity results in increased HSC cycling, at least in young 
Pten
/ and Tsc1
/ HSCs (Yilmaz et al., 2006; C. Chen et al., 
2008). However, it is plausible that in aged mice, mTOR levels do 
not reach a similar threshold as observed in these mutant cells, or 
that mTOR signaling exerts differential effects in dysfunctional 
old HSCs.
Conclusions and future perspectives
Hematopoiesis is a dynamic process that has evolved to generate 
and maintain homeostatic levels of blood cells for the lifetime of 
the organism. The lifelong persistence of HSCs is likely due to 
their acquisition of a quiescent phenotype upon maturity of the 
host, as well as their localization to specialized niches in the BM 
cavity wherein extrinsic cues regulate their cell cycle activity. 
Both of these features can be envisioned as strategies to limit the 
frequency and severity of potentially damaging replicative stresses. 
The aging hematopoietic system serves as a compelling model 
in which to examine the limitations of these protective strate-
gies. The work reviewed here suggests that an old hematopoietic 717 HSC cell cycle regulation • Pietras et al.
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